C3.ai's Turnaround Faces Deep Skepticism as Revenue Plunges
Revenue collapse and margin erosion Revenue fell 36% in FY2026 and gross margin dropped from 62% to 22%, with free cash flow at negative $192 million. FY2027 guidance implies further shrinkage, raising doubts about the business's stability.
This point explains the core financial deterioration that pressured the stock.
Early turnaround signs emerge Q1 FY2027 bookings jumped 73% with new deals from Ford, J&J, and federal agencies. Free cash flow turned positive at $2.1 million, and a 40% headcount cut saves about $135 million annually.
This point highlights the positive operational changes that could support a recovery.
CEO health absence and sales disruption CEO Thomas Siebel's health-related absence caused sales to 'fall off a cliff,' though he returned in June. The disruption added uncertainty during an already challenging period.
This point identifies a key leadership risk that hurt sales and investor confidence.
Intense competition and high short interest Competitors like Palantir and Snowflake are growing far faster, while short interest at 42% signals deep skepticism. Fed rate uncertainty adds pressure, making the turnaround harder.
This point captures external competitive and market pressures that weigh on the stock.